Effect of exercise training on liver function in adults who are overweight or exhibit fatty liver disease: a systematic review and meta-analysis
Date
2016-06-17Author
Subject
Metadata
Show full item recordAbstract
<jats:sec><jats:title>Objective</jats:title><jats:p>Exercise training has been shown to have beneficial effects on liver function in adults overweight or with fatty liver disease. To establish which exercise programme characteristics were likely to elicit optimal improvements.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Systematic review and meta-analysis of randomised, controlled trials.</jats:p></jats:sec><jats:sec><jats:title>Data sources</jats:title><jats:p>PubMed, CINAHL and Cochrane controlled trials registry searched (1966 to 2 October 2015).</jats:p></jats:sec><jats:sec><jats:title>Eligibility criteria for selecting studies</jats:title><jats:p>Exercise intervention, with or without dietary intervention, versus usual care in adults undertaking, exercise training, who were overweight, obese or exhibited fatty liver disease (non-alcoholic fatty liver disease or non-alcoholic steatohepatitis).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We included 21 randomised controlled trials, totalling 1530 participants. Exercise intervention studies with total exercise programme workload >10 000 kcal produced significant improvements in intrahepatic fat, −3.46% (95% CI −5.20% to −1.73%), p<0.0001, I<jats:sup>2</jats:sup>=73%; effect size (standardised mean difference, SMD) −1.77 (−3.11 to −0.42), p=0.01, I<jats:sup>2</jats:sup>=77%. When data from only exercise studies were pooled, there was a reduction in fasting free fatty acids (FFAs) −74.15 µmol/L (95% CI −118.47 to −29.84), p=0.001, I<jats:sup>2</jats:sup>=67% with a large effect size (SMD) −0.94 (−1.36 to −0.52), p<0.0001, I<jats:sup>2</jats:sup>=0%. When data from only exercise studies were pooled, there was a significant reduction in insulin MD −1.88 UL (95% CI −3.43 to −0.34), p=0.02, I<jats:sup>2</jats:sup>=31%. The liver enzymes, alanine aminotransferase, aspartate aminotransferase and γ-glutamyl transpeptidase, were not significantly altered with exercise.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Exercise training reduces intrahepatic fat and FFAs while increasing cardiorespiratory fitness. An aggregate exercise programme energy expenditure (>10 000 kcal) may be required to promote reductions in intrahepatic fat.</jats:p></jats:sec>
Collections
Publisher
Place of Publication
Journal
Volume
Issue
Pagination
Recommended, similar items
The following license files are associated with this item:
Related items
Showing items related by title, author, creator and subject.
-
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
Eslam, M; Hashem, AM; Leung, R; Romero-Gomez, M; Berg, T; Dore, GJ; Chan, HLK; Irving, WL; Sheridan, David; Abate, ML; Adams, LA; Mangia, A; Weltman, M; Bugianesi, E; Spengler, U; Shaker, O; Fischer, J; Mollison, L; Cheng, W; Powell, E; Nattermann, J; Riordan, S; McLeod, D; Armstrong, NJ; Douglas, MW; Liddle, C; Booth, DR; George, J; Ahlenstiel, G (Springer Science and Business Media LLCEngland, 2015-05)<jats:title>Abstract</jats:title><jats:p>Tissue fibrosis is a core pathologic process that contributes to mortality in ~45% of the population and is likely to be influenced by the host genetic architecture. Here we ... -
Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey
Sheridan, David; Aithal, G; Alazawi, W; Allison, M; Anstee, Q; Cobbold, J; Khan, S; Fowell, A; McPherson, S; Newsome, PN; Oben, J; Tomlinson, J; Tsochatzis, E (BMJEngland, 2017-04-28)OBJECTIVE: Guidelines for the assessment of non-alcoholic fatty liver disease (NAFLD) have been published in 2016 by National Institute for Health and Care Excellence and European Associations for the study of the ... -
The potential of new tumor endothelium-specific markers for the development of antivascular therapy.
Li, J-L; Harris, AL (United States, 2007-06)Angiogenesis is a hallmark of solid tumors, and disruption of tumor vasculature is an active anticancer therapy in some cases. Several proteins expressed on the surface of tumor endothelium have been identified during the ...